Zomedica Pharmaceuticals Corp (ZOMDF)
Zomedica Announces Second Quarter 2025 Financial Results: Revenue up 14% to $7 Million with 67% Gross Margins and $59 Million in Liquidity to Support Growth
Context Therapeutics Inc. (CNTX)
Context Therapeutics Reports Second Quarter 2025 Operating and Financial Results
McKesson Corporation (MCK)
McKesson Corporation - McKesson Corporation Reports Fiscal 2026 First Quarter Results
Exact Sciences Corporation (EXAS)
8-K (Current report filing) SEC Filing
Inotiv Inc. (NOTV)
Inotiv - Inotiv Reports Third Quarter Financial Results for Fiscal 2025 and Provides Business Update
electroCore Inc. (ECOR)
electroCore Announces Second Quarter 2025 Financial Results
Sarepta Therapeutics Inc (SRPT)
Sarepta Therapeutics Announces Second Quarter 2025 Financial Results and Recent Corporate Developments
Pennant Group Inc (PNTG)
Pennant Reports Second Quarter 2025 Results
Veracyte Inc (VCYT)
Veracyte Announces Second Quarter 2025 Financial Results
Goodrx Holdings Inc (GDRX)
GoodRx Reports Second Quarter 2025 Results
biote Corp (BTMD)
Biote Reports Second Quarter 2025 Financial Results
Tandem Diabetes Care Inc (TNDM)
Tandem Diabetes Care Announces Second Quarter 2025 Financial Results and Provides 2025 Annual Guidance
Exagen Inc (XGN)
Exagen Inc. to Participate in Third Quarter Investor Conferences
Surmodics Inc. (SRDX)
Surmodics to Report Third Quarter of Fiscal 2025 Financial Results on August 8
Acadia Pharmaceuticals (ACAD)
Acadia Pharmaceuticals Reports Second Quarter 2025 Financial Results and Operating Overview